US 12221491
PSMD9 inhibitors for the treatment of hepatic lipid dysregulation
granted A61KA61K2039/505A61K31/7115
Quick answer
US patent 12221491 (PSMD9 inhibitors for the treatment of hepatic lipid dysregulation) held by The Regents of the University of California expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Feb 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K31/7115, A61K31/712, A61K31/7125